Published in Am J Cardiol on September 15, 1999
Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science (2000) 7.41
Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med (1999) 6.93
Access to coronary artery bypass surgery by race/ethnicity and gender among patients who are appropriate for surgery. Med Care (1999) 3.07
A novel tableted purgative for colonoscopic preparation: efficacy and safety comparisons with Colyte and Fleet Phospho-Soda. Gastrointest Endosc (2000) 2.71
Clinical success, complications and restenosis rates with excimer laser coronary angioplasty. The Percutaneous Excimer Laser Coronary Angioplasty Registry. Am J Cardiol (1992) 2.08
Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion. J Clin Invest (1986) 1.84
Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation (1999) 1.82
Percutaneous laser thermal angioplasty: initial clinical results with a laser probe in total peripheral artery occlusions. Lancet (1986) 1.72
[A case of chronic pulmonary hypertension after fenfluramine intake]. Wien Klin Wochenschr (1982) 1.72
Genomic instability in the type II TGF-beta1 receptor gene in atherosclerotic and restenotic vascular cells. J Clin Invest (1997) 1.69
Cardiogenic shock complicating acute myocardial infarction--etiologies, management and outcome: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol (2000) 1.66
Expanded indications for laser-assisted balloon angioplasty in peripheral arterial disease. J Vasc Surg (1990) 1.62
Images in cardiovascular medicine. Calcified amorphous tumor of the heart. Circulation (2008) 1.56
Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signalling. Cell Death Differ (2013) 1.49
Percutaneous endocardial transfer and expression of genes to the myocardium utilizing fluoroscopic guidance. Catheter Cardiovasc Interv (2001) 1.44
Effect of ST segment measurement point on performance of standard and heart rate-adjusted ST segment criteria for the identification of coronary artery disease. Circulation (1991) 1.43
The use of theranostic gadolinium-based nanoprobes to improve radiotherapy efficacy. Br J Radiol (2014) 1.41
Final results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) study. Circulation (2000) 1.39
Novel distal occluder washout method for prevention of no-reflow during stenting of saphenous vein grafts. Catheter Cardiovasc Interv (1999) 1.39
"Clinical PET: its time has come?". J Nucl Med (1993) 1.39
Regulation of human interleukin-2 and interferon-gamma gene expression by suppressor T lymphocytes. Scand J Immunol (1991) 1.39
Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart. J Thorac Cardiovasc Surg (1998) 1.37
Tumour stem cell-targeted treatment: elimination or differentiation. Ann Oncol (2006) 1.25
Enhancement of radiation response in p53-deficient cancer cells by the Aurora-B kinase inhibitor AZD1152. Oncogene (2007) 1.23
The Lugano statements on controlled clinical trials. J Int Med Res (1987) 1.23
Percutaneous transmyocardial laser revascularisation for severe angina: the PACIFIC randomised trial. Potential Class Improvement From Intramyocardial Channels. Lancet (2000) 1.22
Control of Drosophila head segment identity by the bZIP homeotic gene cnc. Development (1995) 1.19
Decreased type II/type I TGF-beta receptor ratio in cells derived from human atherosclerotic lesions. Conversion from an antiproliferative to profibrotic response to TGF-beta1. J Clin Invest (1995) 1.18
MR imaging of articular cartilage of the knee: new methods using ultrashort TEs. AJR Am J Roentgenol (1998) 1.16
Reactions of cobalt(I) supernucleophiles. The alkylation of vitamin B12s cobaloximes(I), and related compounds. J Am Chem Soc (1969) 1.15
Prostacyclin: haemodynamic and metabolic effects in patients with coronary artery disease. Lancet (1981) 1.14
Dietary and hormonal regulation of hepatic biosynthetic and catabolic enzymes of serine metabolism in rats. Endocrinology (1972) 1.12
Anterior cruciate ligament injury: fast spin-echo MR imaging with arthroscopic correlation in 217 examinations. AJR Am J Roentgenol (1998) 1.11
Inhibitors to monoclonal antibody purified factor VIII. Lancet (1990) 1.11
Biodistribution of Tc-99m methoxy-isobutyl-isonitrile (MIBI) in humans. Eur J Nucl Med (1989) 1.10
Treatment outcome and survival in participants of phase I oncology trials carried out from 2003 to 2006 at Institut Gustave Roussy. Ann Oncol (2007) 1.09
The history of interventional cardiology: cardiac catheterization, angioplasty, and related interventions. Am Heart J (1995) 1.09
Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. Hirulog Angioplasty Study Investigators. N Engl J Med (1995) 1.06
Experimental angioplasty: circumferential distribution of laser thermal energy with a laser probe. J Am Coll Cardiol (1985) 1.06
Sequential research-related biopsies in phase I trials: acceptance, feasibility and safety. Ann Oncol (2011) 1.04
Human percutaneous and intraoperative laser thermal angioplasty: initial clinical results as an adjunct to balloon angioplasty. J Vasc Surg (1987) 1.02
Paraoxonase activity in high-density lipoproteins: a comparison between healthy and obese females. J Clin Endocrinol Metab (2004) 1.01
Spontaneous spinal epidural hematoma with spinal cord compression complicating plasma cell myeloma. A case report. Spine (Phila Pa 1976) (1998) 1.01
Percutaneous coronary intervention for cardiogenic shock in the SHOCK Trial Registry. Am Heart J (2001) 1.00
Platelet accumulation in experimental angioplasty: time course and relation to vascular injury. Circulation (1987) 1.00
Angiographic and histologic consequences of laser thermal angioplasty: comparison with balloon angioplasty. Circulation (1987) 0.99
The chemistry of rhenium and technetium as related to the use of isotopes of these elements in therapeutic and diagnostic nuclear medicine. Int J Rad Appl Instrum B (1986) 0.99
The expression of TGF-beta receptors in human atherosclerosis: evidence for acquired resistance to apoptosis due to receptor imbalance. J Mol Cell Cardiol (1999) 0.98
Evaluation of the efficacy and safety of etoricoxib compared with naproxen in two, 138-week randomised studies of patients with osteoarthritis. Ann Rheum Dis (2006) 0.98
Letter: Reverse transcriptase in plasma of patients with breast cancer. Lancet (1974) 0.98
Focal angiogen therapy using intramyocardial delivery of an adenovirus vector coding for vascular endothelial growth factor 121. Ann Thorac Surg (2000) 0.97
Percutaneous coronary laser thermal angioplasty. J Am Coll Cardiol (1986) 0.97
A randomized, placebo-controlled trial of enoxaparin after high-risk coronary stenting: the ATLAST trial. J Am Coll Cardiol (2001) 0.96
Preclinical and clinical models of lung cancer chemoprevention. Hematol Oncol Clin North Am (1998) 0.96
The nucleophilicity of vitamin B12. J Am Chem Soc (1968) 0.95
Laser angioplasty for limb salvage: observations on early results. J Vasc Surg (1989) 0.95
Angiographic findings and clinical correlates in patients with cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol (2000) 0.94
Total recall of radiotherapy with mTOR inhibitors: a novel and potentially frequent side-effect? Ann Oncol (2011) 0.94
Beneficial effect of enhanced myocardial carbohydrate utilisation after oxfenicine (L-hydroxyphenylglycine) in angina pectoris. Eur Heart J (1980) 0.94
Enhancement of radiation response by inhibition of Aurora-A kinase using siRNA or a selective Aurora kinase inhibitor PHA680632 in p53-deficient cancer cells. Br J Cancer (2007) 0.93
Reduction in angioplasty complications after the introduction of coronary stents: results from a consecutive series of 2242 patients. Am Heart J (1996) 0.93
Transluminal angioplasty in experimental atherosclerosis. Analysis for embolization using an in vivo perfusion system. Circulation (1982) 0.93
Specific inhibition of eIF-5A and collagen hydroxylation by a single agent. Antiproliferative and fibrosuppressive effects on smooth muscle cells from human coronary arteries. J Clin Invest (1995) 0.93
Serum sialyltransferase levels as a parameter in the diagnosis and follow-up of gastrointestinal tumors. Cancer Res (1980) 0.92
MR imaging of articular cartilage using driven equilibrium. Magn Reson Med (1999) 0.92
Lipoprotein(a) plasma concentrations, apolipoprotein (a) polymorphism and family history of coronary heart disease in patients with essential hypertension. J Cardiovasc Risk (1996) 0.91
Effect of antiplatelet therapy on restenosis after experimental angioplasty. Am J Cardiol (1984) 0.91
Carcinosarcoma of the nose and paranasal sinuses-a case report. Rhinology (1982) 0.91
Pharmacokinetics and safety of OBI-1, a recombinant B domain-deleted porcine factor VIII, in subjects with haemophilia A. Haemophilia (2012) 0.91
T-cell alterations in hemophiliacs treated with commercial clotting factor concentrates. Thromb Haemost (1983) 0.90
Caspase independence of radio-induced cell death. Oncogene (2006) 0.89
Cooperative effect of roscovitine and irradiation targets angiogenesis and induces vascular destabilization in human breast carcinoma. Cell Prolif (2009) 0.89
Decreased DNA-PK activity in human cancer cells exhibiting hypersensitivity to low-dose irradiation. Br J Cancer (2000) 0.89
Gadolinium-DTPA-enhanced magnetic resonance imaging of musculoskeletal infectious processes. Skeletal Radiol (1995) 0.89
Coronary artery perforation during excimer laser coronary angioplasty. The percutaneous Excimer Laser Coronary Angioplasty Registry. J Am Coll Cardiol (1993) 0.89
Normal tissues toxicities triggered by combined anti-angiogenic and radiation therapies: hurdles might be ahead. Br J Cancer (2012) 0.89
Cationic [99mTcIII(DIARS)2(SR)2]+ complexes as potential myocardial perfusion imaging agents (DIARS = o-phenylenebis(dimethylarsine);SR- = thiolate). J Med Chem (1996) 0.89
Restenosis following transluminal angioplasty in experimental atherosclerosis. Arteriosclerosis (1984) 0.89
Symptomatic herniation pits of the femoral neck: anatomic and clinical study. AJR Am J Roentgenol (1997) 0.88
Caffey's disease of the scapula: CT and MR findings. AJR Am J Roentgenol (1997) 0.88
Lymphoid papillary hyperplasia of the palatine tonsils. Am J Surg Pathol (1983) 0.88
Weight cycling and cardiovascular risk factors in obesity. Int J Obes Relat Metab Disord (2004) 0.87
Multiple molecular mechanisms contribute to radiation sensitivity in mantle cell lymphoma. Oncogene (2003) 0.87
DnrD cyclase involved in the biosynthesis of doxorubicin: purification and characterization of the recombinant enzyme. Biochemistry (1999) 0.87
A population-based investigation of the autoantibody profile in mothers of children with atrioventricular block. Scand J Immunol (2011) 0.86
Phase I dose-escalating study of ES-285 given as a three-hour intravenous infusion every three weeks in patients with advanced malignant solid tumors. Invest New Drugs (2012) 0.86
[The effect of raubasine on the vein tonus and venous capacity of the lower leg]. Z Kreislaufforsch (1968) 0.86
[Causal therapeutic management of aplastic anaemia (author's transl)]. Wien Klin Wochenschr (1981) 0.86
Tyrphostin AG 1024 modulates radiosensitivity in human breast cancer cells. Br J Cancer (2001) 0.86
Radiation-induced expression of functional Fas ligand in EBV-positive human nasopharyngeal carcinoma cells. Int J Cancer (2000) 0.85
Sonographic assessment of arterial frequency and distribution within the brachial plexus: a comparison with the cadaveric record. Anaesthesia (2011) 0.85
Evaluation of Graftskin composite grafts on full-thickness wounds on athymic mice. J Burn Care Rehabil (1994) 0.85
Early limitations of coronary excimer laser angioplasty. J Am Coll Cardiol (1991) 0.85